» Articles » PMID: 24955153

MiR-18a Downregulates DICER1 and Promotes Proliferation and Metastasis of Nasopharyngeal Carcinoma

Overview
Specialty General Medicine
Date 2014 Jun 24
PMID 24955153
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Nasopharyngeal carcinoma, common in Southeast Asia and the southern provinces of China, often has metastasized by the time of diagnosis; thus there exists the need for improved diagnosis and treatment. Accumulating evidence indicates that microRNAs (miRNAs), which post-transcriptionally regulate protein expression, contribute to the processes of tumorigenesis, including metastasis and cellular invasion. Here, we studied the effect of one miRNA, miR-18a-which is believed to target the miRNA-processing enzyme DICERl-on nasopharyngeal carcinoma. In situ hybridization revealed that miR-18a was more highly expressed in nasopharyngeal carcinoma tissues than in control tissues (P < 0.05), and the overexpression correlated with clinical stage and lymph node metastasis (P < 0.05), but not with age and gender (P > 0.05). In vitro analysis of HK1 nasopharyngeal carcinoma cells transfected with miR-18a exhibited significantly decreased expression of DICER1 mRNA and protein but significantly increased proliferation and invasion properties compared to control cells (P < 0.05). Finally, nude mice injected with miR-18a transfected-HK1 cells displayed significantly increased tumor growth and lung metastasis in vivo (P < 0.05). These findings suggest that miR-18a expression can promote proliferation and metastasis of nasopharyngeal carcinoma cells and that these activities may occur through its regulation of DICER1.

Citing Articles

Tumor-Educated Platelet miR-18a-3p as a Novel Liquid-Biopsy Biomarker for Early Diagnosis and Chemotherapy Efficacy Monitoring in Nasopharyngeal Carcinoma.

Sun K, Wang H, Xu X, Wei X, Su J, Zhu K Front Oncol. 2021; 11:736412.

PMID: 34692511 PMC: 8526886. DOI: 10.3389/fonc.2021.736412.


Circulating plasma exosomal miRNA profiles serve as potential metastasis-related biomarkers for hepatocellular carcinoma.

Huang C, Tang S, Shen D, Li X, Liang L, Ding Y Oncol Lett. 2021; 21(2):168.

PMID: 33552286 PMC: 7798106. DOI: 10.3892/ol.2021.12429.


miR-18a Contributes to Preeclampsia by Downregulating Smad2 (Full Length) and Reducing TGF-β Signaling.

Xu P, Li Z, Wang Y, Yu X, Shao X, Li Y Mol Ther Nucleic Acids. 2020; 22:542-556.

PMID: 33230456 PMC: 7566009. DOI: 10.1016/j.omtn.2020.09.019.


Exosomal Delivery of AntagomiRs Targeting Viral and Cellular MicroRNAs Synergistically Inhibits Cancer Angiogenesis.

Wang J, Jiang Q, Faleti O, Tsang C, Zhao M, Wu G Mol Ther Nucleic Acids. 2020; 22:153-165.

PMID: 32927364 PMC: 7494942. DOI: 10.1016/j.omtn.2020.08.017.


Diagnostic and Prognostic Indications of Nasopharyngeal Carcinoma.

E A R E, Irekeola A, Yean Yean C Diagnostics (Basel). 2020; 10(9).

PMID: 32825179 PMC: 7554987. DOI: 10.3390/diagnostics10090611.


References
1.
Borchert G, Lanier W, Davidson B . RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol. 2006; 13(12):1097-101. DOI: 10.1038/nsmb1167. View

2.
Barker E, Cervigne N, Reis P, Goswami R, Xu W, Weinreb I . microRNA evaluation of unknown primary lesions in the head and neck. Mol Cancer. 2009; 8:127. PMC: 2806863. DOI: 10.1186/1476-4598-8-127. View

3.
Baranwal S, Alahari S . miRNA control of tumor cell invasion and metastasis. Int J Cancer. 2009; 126(6):1283-90. PMC: 2950784. DOI: 10.1002/ijc.25014. View

4.
Landau D, Slack F . MicroRNAs in mutagenesis, genomic instability, and DNA repair. Semin Oncol. 2011; 38(6):743-51. PMC: 3217196. DOI: 10.1053/j.seminoncol.2011.08.003. View

5.
Cao Y, DePinho R, Ernst M, Vousden K . Cancer research: past, present and future. Nat Rev Cancer. 2011; 11(10):749-54. DOI: 10.1038/nrc3138. View